![](/img/cover-not-exists.png)
Degarelix: A Novel Gonadotropin-Releasing Hormone (GnRH) Receptor Blocker—Results from a 1-yr, Multicentre, Randomised, Phase 2 Dosage-Finding Study in the Treatment of Prostate Cancer
Hendrik Van Poppel, Bertrand Tombal, Jean J. de la Rosette, Bo-Eric Persson, Jens-Kristian Jensen, Tine Kold OlesenVolume:
54
Year:
2008
Language:
english
Pages:
11
DOI:
10.1016/j.eururo.2008.04.065
File:
PDF, 647 KB
english, 2008